Feb 01, 2021
Creso Pharma (ASX: CPH) is prepared to meet demand as OTC sales of low-dose cannabidiol products start in Australian pharmacies.
Dec 15, 2020
Creso Pharma (ASX: CPH) is positioned to significantly benefit from a TGA decision to down-schedule low dose CBD preparations.
Get expert stock analysis direct in your inbox
Join OurMailing List
Discover Small CapBiotech Stocks
Join thousands of other Investors following our stock commentary for Free